Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7716
+0.0136 (1.79%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Rein Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Net Income | -50.21 | -49.87 | -58.89 | -59.15 | -61.27 | -62.88 | -29.24 | -25.22 | -18.07 | -15.73 | -12.94 | -17.48 | -23.69 | -27.33 | -29.58 | -29.92 | -27.61 | -26.16 | -24.36 | -22.68 |
Depreciation & Amortization | - | 0 | 0 | - | - | 0.06 | 0.12 | 0.13 | 0.14 | 0.12 | 0.11 | 0.14 | 0.17 | 0.17 | 0.17 | 0.16 | 0.16 | 0.12 | 0.09 | 0.07 |
Stock-Based Compensation | 2.12 | 2.22 | 2.1 | 1.16 | 1.23 | 1.12 | 1.25 | 0.98 | 0.95 | 1.19 | 1.34 | 1.56 | 1.79 | 2.08 | 2.27 | 2.48 | 2.32 | 2.26 | 2.02 | 1.82 |
Other Adjustments | 0.62 | 29.15 | - | - | - | 37 | 0.18 | 0.18 | 0.13 | -0 | -0.28 | -0.34 | -0.31 | -0.21 | -0.06 | 0.08 | 0.18 | -0.21 | -0.25 | 0.17 |
Changes in Accounts Payable | 5.12 | 3.07 | -0.17 | 5.25 | -1.01 | -0.28 | -3.86 | -3.81 | -2.75 | -4.98 | -0.46 | -1.61 | -0.57 | 0.51 | -0.09 | 0.73 | 0.47 | -0.39 | 0 | -0.01 |
Changes in Accrued Expenses | -2.37 | -2.62 | -2.95 | -2.49 | 2.45 | 1.69 | 1.54 | 1.2 | -1.95 | -0.38 | -2.38 | -2.25 | -0.57 | -1.57 | 0.09 | 0.15 | 0.9 | 1.01 | -0.13 | 0.08 |
Changes in Other Operating Activities | -0.33 | -1.31 | 3.1 | -1.44 | -0.05 | 1 | 2.14 | 0.9 | 1.18 | -0.02 | 0.81 | 0.81 | 1.43 | 1.48 | 0.49 | -0.62 | -1.03 | -0.38 | 0.44 | 0.99 |
Operating Cash Flow | -16.61 | -19.36 | -20.95 | -21.22 | -23.2 | -22.29 | -27.87 | -25.69 | -20.42 | -19.81 | -13.83 | -19.16 | -21.73 | -24.87 | -26.71 | -27 | -25.08 | -23.75 | -22.19 | -19.97 |
Operating Cash Flow Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Capital Expenditures | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | -0.01 | -0.07 | -0.16 | -0.16 | -0.15 |
Sale of Property, Plant & Equipment | - | - | - | - | - | - | 0 | - | - | 0.04 | - | - | - | - | 0 | - | - | 0.07 | 0.21 | - |
Purchases of Investments | - | - | - | - | - | - | - | - | - | - | -1.94 | -9.75 | -17.14 | -21.85 | -22.66 | -34.57 | -37.17 | -73.58 | -72.83 | -59.38 |
Proceeds from Sale of Investments | - | - | - | - | - | - | 0 | 0.5 | 9 | 16.25 | 22.95 | 34.45 | 39.2 | 48.31 | 46.61 | 58.36 | 50.36 | 37.75 | 34.25 | 12.25 |
Cash Acquisitions | - | - | - | - | - | - | - | - | - | -0.1 | - | - | - | 0 | - | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - | - | -0.1 | 0.45 | 8.95 | 16.2 | 21.06 | 24.7 | 22.06 | 26.46 | 23.95 | 23.85 | 13.19 | -35.92 | -38.53 | -47.14 |
Short-Term Debt Issued | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 |
Net Short-Term Debt Issued (Repaid) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 |
Long-Term Debt Issued | 4.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | 4.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Issuance of Common Stock | 1.44 | 6.91 | 0.85 | 0.12 | 11.53 | 17.82 | 10.79 | 11.04 | - | 15.79 | - | - | - | - | 0 | 0.03 | -0.02 | 111.24 | 55.58 | 55.88 |
Net Common Stock Issued (Repurchased) | 1.44 | 6.91 | 0.85 | 0.12 | 11.53 | 17.82 | 10.79 | 11.04 | - | 15.79 | - | - | - | - | 0 | 0.03 | -0.02 | 111.24 | 55.58 | 55.88 |
Other Financing Activities | - | 2.85 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Financing Cash Flow | 13.67 | 9.76 | 7.35 | 5.01 | 18.56 | 17.82 | 33.61 | 34.06 | - | 15.79 | - | - | - | - | 0 | 0.03 | 0.05 | 55.66 | 59.9 | 60.17 |
Foreign Exchange Rate Adjustments | - | -0.04 | -0.03 | - | - | - | -0.06 | -0.06 | - | -0.06 | - | - | - | - | - | - | - | - | - | - |
Net Cash Flow | -2.98 | -9.65 | -13.63 | -16.22 | -4.64 | -4.47 | 5.58 | 8.75 | 4.26 | 12.12 | 7.23 | 5.54 | 0.33 | 1.59 | -2.76 | -3.12 | -11.83 | -4.01 | -0.82 | -6.94 |
Free Cash Flow | -16.61 | -19.36 | -20.95 | -21.22 | -23.2 | -22.29 | -27.87 | -25.69 | -20.42 | -19.81 | -13.83 | -19.16 | -21.73 | -24.87 | -26.71 | -27.01 | -25.15 | -23.91 | -22.35 | -20.12 |
Free Cash Flow Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.60 | -0.76 | -0.89 | -0.95 | -1.09 | -1.24 | -2.04 | -2.74 | -3.69 | -4.31 | -3.04 | -4.22 | -4.78 | -5.48 | -5.89 | -5.96 | -5.55 | -5.38 | -5.85 | -6.33 |
Levered Free Cash Flow | -43.49 | -50.74 | -58.9 | -57.83 | -59.88 | -60.41 | -29.3 | -26.8 | -21.45 | -20.99 | -14.87 | -20.39 | -23.22 | -26.74 | -28.92 | -29.5 | -27.19 | -25.96 | -24.11 | -21.7 |
Unlevered Free Cash Flow | -47.83 | -50.78 | -60.78 | -60.03 | -62.12 | -61.08 | -29.67 | -27.1 | -21.85 | -21.54 | -15.61 | -21.1 | -23.77 | -27.06 | -29.1 | -29.65 | -27.62 | -26.4 | -23.73 | -21.24 |